Stocks
GlaxoSmithKline (GSK) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.49 | 1.52 | 1.49 | 1.36 | 1.36 | -0.41 | |||
| Changes by years, y/y, % | -42% | +2% | -2% | -8% | 0% | -14.7% | |||
GlaxoSmithKline. Debt/EBITDA
GlaxoSmithKline. Debt/EBITDA, changes, %
GlaxoSmithKline (GSK) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 1.44 | 1.41 | -0.32 | 1.40 | -0.40 | -0.41 | ||
| Changes by years, y/y, % | -9% | -14% | -124% | -11% | -130% | |||
| Changes by quarters, q/q, % | +14% | -2% | -123% | -535% | -129% | |||
